← Evidence map

RetractedArticleProceedings of the National Academy of Sciences of the United States of America2000

Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.

T Arichi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 10618412